Retraction to: Hypertension Research (2008) 31, 1171–1176; doi:10.1291/hypres.31.1171
The authors have indicated to the journal that this paper should be withdrawn in response to the interim report on the Shiga Microalbuminuria Reduction Trial (SMART), and in consequence of the retraction of the main report from the same trial.1 After careful consideration, Hypertension Research editorial committee formally retracts this paper with agreement of the authors.
References
The Shiga Microalbuminuria Reduction Trial (SMART) Group. Reduction of microalbuminuria in patients with type 2 diabetes: The Shiga Microalbuminuria Reduction Trial (SMART). Diabetes Care 2007; 30: 1581–1583.
Author information
Consortia
Additional information
The online version of the original article can be found at 10.1291/hypres.31.1171
About this article
Cite this article
The Shiga Microalbuminuria Reduction Trial (SMART) Group. Retraction Note: Impact of Renin-Angiotensin System Inhibition on Microalbuminuria in Type 2 Diabetes: A Post Hoc Analysis of the Shiga Microalbuminuria Reduction Trial (SMART). Hypertens Res 37, 598 (2014). https://doi.org/10.1038/hr.2014.69
Published:
Issue Date:
DOI: https://doi.org/10.1038/hr.2014.69